|
"johnston a"的相關文件
顯示項目 1-9 / 9 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2021-06-12 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
|
Chang, KY;Chiang, NJ;Wu, SY;Yen, CJ;Chen, SH;Yeh, YM;Li, CF;Feng, XX;Wu, K;Johnston, A;Bomalaski, JS;Wu, BW;Gao, JJ;Subudhi, SK;Kaseb, AO;Blando, JM;Yadav, SS;Szlosarek, PW;Chen, LT |
| 國家衛生研究院 |
2021-03-30 |
Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia
|
Tsai, HJ;Hsiao, HH;Hsu, YT;Liu, YC;Kao, HW;Liu, TC;Cho, SF;Feng, X;Johnston, A;Bomalaski, JS;Kuo, MC;Chen, TY |
| 國立成功大學 |
2021 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
|
Chang, K.-Y.;Chiang, N.-J.;Wu, S.-Y.;Yen, C.-J.;Chen, S.-H.;Yeh, Yeh Y.-M.;Li, C.-F.;Feng, X.;Wu, K.;Johnston, A.;Bomalaski, J.S.;Wu, B.-W.;Gao, J.;Subudhi, Subudhi S.K.;Kaseb, A.O.;Blando, J.M.;Yadav, S.S.;Szlosarek, P.W.;Chen, L.-T. |
| 國立成功大學 |
2021 |
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study
|
Harding, J.J.;Yang, T.-S.;Chen, Y.-Y.;Feng, Y.-H.;Yen, C.-J.;Ho, C.-L.;Huang, W.-T.;El, Dika I.;Akce, M.;Tan, B.;Cohen, S.A.;Meyer, T.;Sarker, D.;Lee, D.-W.;Ryoo, B.-Y.;Lim, H.Y.;Johnston, A.;Bomalaski, J.S.;O’Reilly, E.M.;Qin, S.;Abou-Alfa, G.K. |
| 臺大學術典藏 |
2020-03-02T02:58:26Z |
FloodCitiSense: Early Warning Service for Urban Pluvial Floods for and by Citizens and City Authorities
|
Verbeiren B.; Seyoum S.D.; Lubbad I.; Xin T.; ten Veldhuis M.-C.; Onof C.; Wang L.-P.; Ochoa-Rodriguez S.; Veeckman C.; Boonen M.; See L.; Nalpas D.; O’Brien B.; Johnston A.; Willems P.; LI-PEN WANG |
| 臺大學術典藏 |
2020-03-02T02:58:26Z |
Surface water flood warnings in England: overview, assessment and recommendations based on survey responses and workshops
|
Ochoa-Rodr?guez S.; Wang L.-P.; Thraves L.; Johnston A.; Onof C.; LI-PEN WANG |
| 國家衛生研究院 |
2018-05 |
A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers
|
Chang, KY;Chiang, NJ;Yen, CJ;Wu, SY;Chen, SH;Johnston, A;Bomalaski, JS;Wu, BW;Chen, LT |
| 國家衛生研究院 |
2018-04-05 |
ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G;Qin, S;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, G;Harris, WP;Chen, Z;Hubner, RA;Meyer, T;Sun, W;Harding, JJ;Hollywood, EM;Ma, J;Wan, PJ;Ly, M;Bomalaski, J;Johnston, A;Lin, CC;Chao, Y;Chen, LT |
| 國立成功大學 |
2018 |
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G.K.;Qin, S.;Ryoo, B.-Y.;Lu, S.-N.;Yen, C.-J.;Feng, Y.-H.;Lim, H.Y.;Izzo, F.;Colombo, M.;Sarker, D.;Bolondi, L.;Vaccaro, G.;Harris, W.P.;Chen, Z.;Hubner, R.A.;Meyer, T.;Sun, W.;Harding, J.J.;Hollywood, E.M.;Ma, J.;Wan, P.J.;Ly, M.;Bomalaski, J.;Johnston, A.;Lin, C.-C.;Chao, Y.;Chen, L.-T. |
顯示項目 1-9 / 9 (共1頁)
1
每頁顯示[10|25|50]項目
|
